These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9853619)

  • 1. Cell surface expression of a human IgG Fc chimera activates macrophages through Fc receptors.
    Stabila PF; Wong SC; Kaplan FA; Tao W
    Nat Biotechnol; 1998 Dec; 16(13):1357-60. PubMed ID: 9853619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of divalent H-2Kd/IgG2aFc fusion protein to murine macrophage via Fc-FcR interaction.
    Xiao W; Chen X; Lin Zhou ; Lu S; Liang Z; Wu X
    Cell Mol Immunol; 2007 Apr; 4(2):147-51. PubMed ID: 17571461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface display of IgG Fc on baculovirus vectors enhances binding to antigen-presenting cells and cell lines expressing Fc receptors.
    Martyn JC; Cardin AJ; Wines BD; Cendron A; Li S; Mackenzie J; Powell M; Gowans EJ
    Arch Virol; 2009; 154(7):1129-38. PubMed ID: 19557497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of neonatal FcR in regulating the serum half-life of therapeutic proteins containing the Fc domain of human IgG1: a comparative study of the affinity of monoclonal antibodies and Fc-fusion proteins to human neonatal FcR.
    Suzuki T; Ishii-Watabe A; Tada M; Kobayashi T; Kanayasu-Toyoda T; Kawanishi T; Yamaguchi T
    J Immunol; 2010 Feb; 184(4):1968-76. PubMed ID: 20083659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural requirements of the cytoplasmic domains of the human macrophage Fc gamma receptor IIa and B cell Fc gamma receptor IIb2 for the endocytosis of immune complexes.
    Engelhardt W; Gorczytza H; Butterweck A; Mönkemann H; Frey J
    Eur J Immunol; 1991 Sep; 21(9):2227-38. PubMed ID: 1832386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of ATR-Fc fusion protein in CHO cells].
    Gao LH; Hu XW; Chen W; Xu JJ; Zhao J; Chen HP
    Sheng Wu Gong Cheng Xue Bao; 2005 Sep; 21(5):826-31. PubMed ID: 16285529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient production of human Fas receptor extracellular domain-human IgG1 heavy chain Fc domain fusion protein using baculovirus/silkworm expression system.
    Muraki M; Honda S
    Protein Expr Purif; 2010 Oct; 73(2):209-16. PubMed ID: 20576530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and ligand binding assays of soluble cytokine receptor-immunoglobulin fusion proteins.
    Brown SJ; Becherer KA; Blumeyer K; Kautzer C; Axelrod F; Le H; McConnell SJ; Whalley A; Spinella DG
    Protein Expr Purif; 1998 Oct; 14(1):120-4. PubMed ID: 9758759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uptake of recombinant myeloperoxidase, free or fused to Fc gamma, by macrophages enhances killing activity toward micro-organisms.
    Tournay C; Courtoy PJ; Marodi L; Totté P; Werenne J; Jacquet A; Garcia-Quintana L; Bollen A; Moguilevsky N
    DNA Cell Biol; 1996 Aug; 15(8):617-24. PubMed ID: 8769563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinoembryonic antigen-immunoglobulin Fc fusion protein (CEA-Fc) for identification and activation of anti-CEA immunoglobulin-T-cell receptor-modified T cells, representative of a new class of Ig fusion proteins.
    Ma Q; DeMarte L; Wang Y; Stanners CP; Junghans RP
    Cancer Gene Ther; 2004 Apr; 11(4):297-306. PubMed ID: 15002034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types.
    Kanda Y; Yamada T; Mori K; Okazaki A; Inoue M; Kitajima-Miyama K; Kuni-Kamochi R; Nakano R; Yano K; Kakita S; Shitara K; Satoh M
    Glycobiology; 2007 Jan; 17(1):104-18. PubMed ID: 17012310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Sindbis virus-based vectors to Fc receptor-positive cell types.
    Klimstra WB; Williams JC; Ryman KD; Heidner HW
    Virology; 2005 Jul; 338(1):9-21. PubMed ID: 15922395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving the efficacy of antibody-interleukin 2 fusion proteins by reducing their interaction with Fc receptors.
    Gillies SD; Lan Y; Lo KM; Super M; Wesolowski J
    Cancer Res; 1999 May; 59(9):2159-66. PubMed ID: 10232603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The N-terminal end of the CH2 domain of chimeric human IgG1 anti-HLA-DR is necessary for C1q, Fc gamma RI and Fc gamma RIII binding.
    Morgan A; Jones ND; Nesbitt AM; Chaplin L; Bodmer MW; Emtage JS
    Immunology; 1995 Oct; 86(2):319-24. PubMed ID: 7490135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of soluble recombinant TGF-beta type II receptor fused with the Fc portion of human IgG1 (sTbetaRII-Fc) in NS0 cells.
    Kwiatkowska EP; Kazimierczak U; Mackiewicz A; Kowalczyk DW
    Acta Biochim Pol; 2006; 53(2):361-9. PubMed ID: 16733563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation and characterization of a single-gene mouse-human chimeric antibody against hepatitis B surface antigen.
    Bose B; Khanna N; Acharya SK; Sinha S
    J Gastroenterol Hepatol; 2006 Sep; 21(9):1439-47. PubMed ID: 16911690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SEEDbodies: fusion proteins based on strand-exchange engineered domain (SEED) CH3 heterodimers in an Fc analogue platform for asymmetric binders or immunofusions and bispecific antibodies.
    Davis JH; Aperlo C; Li Y; Kurosawa E; Lan Y; Lo KM; Huston JS
    Protein Eng Des Sel; 2010 Apr; 23(4):195-202. PubMed ID: 20299542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and expression of polymeric immunoglobulin fusion proteins: a strategy for targeting low-affinity Fcgamma receptors.
    White DM; Jensen MA; Shi X; Qu Zx ; Arnason BG
    Protein Expr Purif; 2001 Apr; 21(3):446-55. PubMed ID: 11281720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-secretion neutralization of transgene-derived effect: soluble erythropoietin receptor/IgG1Fc expressed in liver neutralizes erythropoietin produced in muscle.
    Maruyama H; Higuchi M; Higuchi N; Kameda S; Saito M; Sugawa M; Matsuzaki J; Neichi T; Yokoyama S; Miyazaki Y; Miyazaki J; Gejyo F
    J Gene Med; 2004 Feb; 6(2):228-37. PubMed ID: 14978776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of antibody-dependent mechanisms of tumor cell lysis by a targeted activator of complement.
    Imai M; Ohta R; Varela JC; Song H; Tomlinson S
    Cancer Res; 2007 Oct; 67(19):9535-41. PubMed ID: 17909064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.